FFA
CRL icon

Founders Financial Alliance’s Charles River Laboratories CRL Stock Holding History

Founders Financial Alliance’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,264
Closed -$266K – 481
2023
Q2 		$266K Buy
+1,264
New +$251K 0.1% 206
2020
Q4 		– Sell
-45
Closed -$10K – 597
2020
Q3 		$10K Buy
+45
New +$9.34K 0.01% 759

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Founders Financial Alliance's CRL Position: Q3 2023 in Review

Founders Financial Alliance sold out of Charles River Laboratories (CRL) in Q3 2023, closing a stake of 1,264 shares — an estimated $266K sold.

Founders Financial Alliance first reported a position in CRL in Q3 2020 and held it in 2 quarters. The position peaked at $266K in Q2 2023. 621 funds tracked by Wall St. Rank hold CRL as of Q3 2023.

  • Founders Financial Alliance reported no remaining Charles River Laboratories position as of Q3 2023 after selling out during the quarter.
  • Founders Financial Alliance sold 1,264 Charles River Laboratories shares in Q3 2023, an estimated $266K.
  • Founders Financial Alliance first reported a position in Charles River Laboratories in Q3 2020 and held it in 2 quarters.
  • Founders Financial Alliance's Charles River Laboratories position peaked at $266K in Q2 2023.
  • 621 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2023.

Based on Founders Financial Alliance's 13F filing for Q3 2023, filed 13 Nov 2023.